Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Incidence of Germline ATM Variants in a Consecutive Clinical Cohort of CLL Patients

Benjamin L. Lampson, MD PhD, Svitlana Tyekucheva, PhD, Conner J. Shaughnessy, Annette S. Kim, MD PhD, Jennifer R. Brown, MD PhD

Blood (2019) 134 (Supplement_1): 1731.

https://doi.org/10.1182/blood-2019-127180

Published: 2019

Journal Articles

Beyond the Routine CBC: Research CBC Parameters Associated with Myelodysplastic Syndromes and Underlying Mutations

Olga Pozdnyakova, MD PhD, Radu Stefan Niculescu, PhD, Tracey Kroll, BSc, Lisa Golemme, MLS (ASCP), MS, Nolan Raymond, MLS (ASCP), Debra Briggs, MT(ASCP), MS, Annette S. Kim, MD PhD

Blood (2019) 134 (Supplement_1): 5419.

https://doi.org/10.1182/blood-2019-125654

Published: 2019

Journal Articles

Recipients of Myelotoxic Chemotherapy Have Increased Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with a Typical Distribution of Chip-Associated Mutations

Adam J Olszewski, MD, Anna Dorota Chorzalska, PhD, Annette S. Kim, MD PhD, Peter J. Quesenberry, MD, Mary L Lopresti, DO, Mary Anne Fenton, MD, John L. Reagan, MD, James Butera, MD, Ilyas Sahin, MD, Celine Hamel, CRA, Jordan Robison, CRA, Max Petersen, Patrycja Dubielecka, PhD

Blood (2018) 132 (Supplement 1): 3841.

https://doi.org/10.1182/blood-2018-99-111436

Published: 2018

Journal Articles

Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities

Rahul S. Vedula, MD, Marlise R. Luskin, MD, Kevin Copson, MA, Priti Kumari, M.S., Anne Charles, BS, Annette S. Kim, MD PhD, Elizabeth A Morgan, MD, Gregory A. Abel, MD MPH, Richard M. Stone, MD, Andrew A. Lane, MD PhD, R. Coleman Lindsley, MD, PhD

Blood (2018) 132 (Supplement 1): 1819.

https://doi.org/10.1182/blood-2018-99-118746

Published: 2018

Journal Articles

Resistance to Inotuzumab Ozogamicin in a B-ALL Patient with TET2 and DNMT3A Mutations and Myeloid Lineage Switch

Christopher B. Hergott, MD PhD, Annette S. Kim, MD, PhD, Martha Wadleigh, MD, R. Coleman Lindsley, MD, PhD

Blood (2018) 132 (Supplement 1): 2818.

https://doi.org/10.1182/blood-2018-99-119207

Published: 2018

Journal Articles

Clinical Utility of Routine Targeted Next-Generation Sequencing of Peripheral Blood in the Evaluation of Patients with Cytopenias

Vignesh Shanmugam, MD, Aric Parnes, MD, Elizabeth A Morgan, MD, Annette S. Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3090.

https://doi.org/10.1182/blood-2018-99-117922

Published: 2018

Journal Articles

Mutational Burden in Acute Myeloid Leukemia Is Largely Age Dependent

Aaron C. Shaver, MD PhD, Adam C. Seegmiller, MD PhD, Stephen A. Strickland, MD, Robert D. Daber, PhD, Sanjay R. Mohan, MD, Paul Brent Ferrell, Jr., MD, Cindy Vnencak-Jones, PhD, David R. Head, MD, Annette S. Kim, MD PhD, Mary M. Zutter, MD, Michael R. Savona, MD

Blood (2015) 126 (23): 2605.

https://doi.org/10.1182/blood.V126.23.2605.2605

Published: 2015

Journal Articles

miRNA Predictors of Response to DNA Methyltransferase Inhibitors

Amma Bosompem, MS, Yan Guo, PhD, Sanjay Mohan, MD, Begum Erdogan, MA, Muhammad Raza, MD, C. Michael Jones, MD FACP, Elizabeth A. Griffiths, MD, Annette S. Kim, MD PhD

Blood (2014) 124 (21): 1913.

https://doi.org/10.1182/blood.V124.21.1913.1913

Published: 2014

Journal Articles

Differential Expression of Ribosomal Proteins in Myelodysplastic Syndromes

Elizabeth B Rinker, MD, Julie C. Dueber, MD, Julianne Qualtieri, MD, Jason Tedesco, MD, Begum Erdogan, MA, Annette S. Kim, MD, PhD

Blood (2011) 118 (21): 1710.

https://doi.org/10.1182/blood.V118.21.1710.1710

Published: 2011

Journal Articles

Evidence-Based, Patient-Specific Guidelines Provide Efficient and Cost-Effective Molecular and Cytogenetic Testing in Hematologic Malignancy

Adam C. Seegmiller, MD, PhD, Annette S. Kim, MD, PhD, Claudio A. Mosse, MD, PhD, Mia A. Levy, MD, PhD, Mary Ann Thompson, MD, PhD, Megan K. Kressin, MD, Madan H. Jagasia, MD, Stephen A. Strickland, MD, MSCI, Nishitha M. Reddy, MD, Kristy J. Sinkfield, Samuel A. Santoro, MD, PhD, Mary M. Zutter, MD

Blood (2011) 118 (21): 2073.

https://doi.org/10.1182/blood.V118.21.2073.2073

Published: 2011

Journal Articles

Practice Guidelines for the Interpretation and Reporting of Transient Therapy-Related Single Metaphase Chromosomal Abnormalities Identified by Routine Metaphase Cytogenetics in Bone Marrow Specimens,

Annette S. Kim, MD, PhD, Megan K. Kressin, MD

Blood (2011) 118 (21): 4208.

https://doi.org/10.1182/blood.V118.21.4208.4208

Published: 2011

Journal Articles

Combination Chemotherapy with Rituximab, Gemcitabine, Vinorelbine and Liposomal Doxorubicin As a Salvage Regimen for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Patrick L Stevens, MD, Mahsa Talbott, Meghan E Caldwell, NP, David S Morgan, MD, Annette S. Kim, MD, PhD, John P Greer, MD, Nishitha M. Reddy, MD

Blood (2011) 118 (21): 4954.

https://doi.org/10.1182/blood.V118.21.4954.4954

Published: 2011

Journal Articles

MicroRNA Diagnostic Signature of Myelodysplastic Syndrome.

Crystal Facey, MS, MT, R. Benjamin Isett, John Tobias, PhD, Donald A. Baldwin, PhD, James E. Thompson, MD, Martin Carroll, MD, Annette S. Kim, MD, PhD

Blood (2009) 114 (22): 1763.

https://doi.org/10.1182/blood.V114.22.1763.1763

Published: 2009

NARROW

Incidence of Germline ATM Variants in a Consecutive Clinical Cohort of CLL Patients

Beyond the Routine CBC: Research CBC Parameters Associated with Myelodysplastic Syndromes and Underlying Mutations

Recipients of Myelotoxic Chemotherapy Have Increased Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with a Typical Distribution of Chip-Associated Mutations

Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities

Resistance to Inotuzumab Ozogamicin in a B-ALL Patient with TET2 and DNMT3A Mutations and Myeloid Lineage Switch

Clinical Utility of Routine Targeted Next-Generation Sequencing of Peripheral Blood in the Evaluation of Patients with Cytopenias

Mutational Burden in Acute Myeloid Leukemia Is Largely Age Dependent

miRNA Predictors of Response to DNA Methyltransferase Inhibitors

Differential Expression of Ribosomal Proteins in Myelodysplastic Syndromes

Evidence-Based, Patient-Specific Guidelines Provide Efficient and Cost-Effective Molecular and Cytogenetic Testing in Hematologic Malignancy

Practice Guidelines for the Interpretation and Reporting of Transient Therapy-Related Single Metaphase Chromosomal Abnormalities Identified by Routine Metaphase Cytogenetics in Bone Marrow Specimens,

Combination Chemotherapy with Rituximab, Gemcitabine, Vinorelbine and Liposomal Doxorubicin As a Salvage Regimen for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

MicroRNA Diagnostic Signature of Myelodysplastic Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only